Cargando…
Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
Autores principales: | Bone, H. G., Dempster, D. W., Eisman, J. A., Greenspan, S. L., McClung, M. R., Nakamura, T., Papapoulos, S., Shih, W. J., Rybak-Feiglin, A., Santora, A. C., Verbruggen, N., Leung, A. T., Lombardi, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713920/ https://www.ncbi.nlm.nih.gov/pubmed/26359183 http://dx.doi.org/10.1007/s00198-015-3274-z |
Ejemplares similares
-
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
por: Bone, H. G., et al.
Publicado: (2014) -
Potential role of odanacatib in the treatment of osteoporosis
por: Ng, Kong Wah
Publicado: (2012) -
Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010) -
Role of odanacatib in reducing bone loss due to endodontic disease: An overview
por: Bahuguna, Rachana, et al.
Publicado: (2016) -
Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate
por: Misof, Barbara M., et al.
Publicado: (2016)